2023

BIOEMTECH was present at Thessaloniki for Beyond Expo 2023

BIOEMTECH participated in the panel discussion “A 360 view on startup challenges, ” which Metavallon VC partner George Karantonis moderated by Metavallon VC partner George Karantonis and featuring us, Cogitat, technologies, and Klisto. It was nice to discuss...

Eliza Lambidis, Ph.D. will represent BIOEMTECH in the 25th iSRS in Honoloulou

Only a few days are left for the 25th International Symposium on Radiopharmaceutical Sciences that takes place in Honolulu, Hawaii. Our R&D Radiopharmaceutical Chemist, Dr. Eliza Lambidis will be there, presenting the poster P-128 “A Preclinical Platform to Thoroughly...

First images of γ-eye showing Cu-67 antibody imaging on a lung oncology model

Cu-67 can fully be supported by our BIOEMTECH gamma-eye as shown through a recent study conducted in our laboratories for preclinical research purposes. Following non-invasive in vivo imaging for 6 consecutive days, tumor targeting can be quantified, and the...

What if you could combine a full week of educational talks on preclinical research and hands- n training, with hiking, open-air yoga and leadership sessions on managing a lab team?

Program is out and registrations are open, for this year’s BIOEMTECH‘s Preclinical Imaging Workshop! The 3rd Preclinical Imaging Workshop is taking place in Greece, on October 16th-20th, promising to deliver inspirational educational talks from top scientists on preclinical research,...

Happy to see beta-eye representing the rest of BIOEMTECH “eyes”

The 6th Annual Preclinical Imaging Consortium takes place between May 10 and May 12 at Michigan State University, East Lansing, MI. We thank once more Scintica team for being there to demonstrate our technology along with other great instruments that can boost preclinical...

1st Central-East European LAS Congress

Are you attending the 1st Central-East European LAS Congress, held in Prague, on 30th May – 1st June? If yes, do seize the opportunity to meet, hear and talk with our veterinarian and in vivo Research Consultant Argyro Zacharioudaki and our Head Animal Technologist Nansy...

Copper-67 has just landed at BIOEMTECH Laboratories

Copper-67 has been long considered as an “ideal” radionuclide for radioimmunotherapy and targeted radionuclide therapy, due to its very desirable decay features. It decays by β− and γ-   rays, rendering it with potential for both therapy and SPECT molecular imaging. The...

Scintica and BIOEMTECH announce collaboration to bring advanced molecular screening instrumentation to preclinical scientists worldwide

Scintica, a leading value-added reseller of advanced preclinical research instrumentation, is excited to announce a new collaboration with Bioemtech, dedicated to desktop SPECT, PET, and Optical scanners for use in preclinical research. The partnership aims to expand the availability of our...

It’s great that BIOEMTECH will be represented for the first time at Delphi Economic Forum by our Lab Director Maritina G. Rouchota

BIOEMTECH will be represented for the first time at Delphi Economic Forum by our Lab Director Maritina G. Rouchota participating in the Inclusivity Lounge | Equity, Diversity and Inclusion in Health, which will be held at the heart of the Delphi Economic Forum, next...

Greetings from International Atomic Energy Agency (IAEA) and ISTR23

BIOEMTECH is happy to participate in PRISMAP Project at the session ‘Academia Meets Industry (PRISMAP Experience)’. Dr. George Loudos, BIOEMTECH’s CEO, was there presenting:  Preclinical Imaging of Challenging Isotopes Including Alpha Emitters for Oncological Applications.